The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Pfizer
Adjuvant axitinib dose modification in renal cell carcinoma (RCC): Analysis of the ATLAS study.
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Mundipharma; Novartis; Pfizer; Pharmacyclics; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Eisai; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi; US Biotest
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Tae Gyun Kwon
Research Funding - Chilgok Kyungpook National University Hospital (Inst)
 
Masatoshi Eto
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Ono Pharmaceutical; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Novartis; Ono Pharmaceutical; Pfizer
Research Funding - Ono Pharmaceutical; Pfizer
 
Dingwei Ye
No Relationships to Disclose
 
Hideaki Miyake
No Relationships to Disclose
 
Seong Il Seo
Honoraria - Ipsen; Pfizer
Research Funding - Alvogen
 
Seok-Soo Byun
No Relationships to Disclose
 
Jae-Lyun Lee
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Pfizer; Sanofi/Aventis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Viraj A. Master
No Relationships to Disclose
 
Chi-Fai Ng
Consulting or Advisory Role - Astellas Pharma; Boston Scientific; Janssen
Speakers' Bureau - Amgen; Astellas Pharma; Boston Scientific; Ferring; Janssen
Research Funding - Astellas Pharma; Ferring; Janssen; Olympus
 
Rolf Gerhard Linke
Employment - SFJ Pharmaceuticals Group
Leadership - SFJ Pharmaceuticals Group
 
Brad Rosbrook
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mahgull Nazar Thakur
No Relationships to Disclose
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Lexicon; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Roche
Consulting or Advisory Role - Ipsen; MSD; Pfizer
Research Funding - AstraZeneca (Inst); Ipsen (Inst); MTEM/Threshold (Inst); Pfizer (Inst); Roche
 
Marine Gross-Goupil
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Merck Sharp & Dome; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Ipsen; Merck Sharp & Dome; Pfizer
Travel, Accommodations, Expenses - Amgen (I); Bristol-Myers Squibb; Merck Sharp & Dome; Pfizer; Roche
 
Chao-Hsiang Chang
No Relationships to Disclose